Patent-Nanjing Immunophage Biomedical Co., Ltd

CN

Paper
Patent

CN2024/085942

COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS

2024
CN2024/073261

COMPOUNDS AND THEIR USES AS GPR17 ANTAGONISTS

2024
CN2023/143153

COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THE USE THEREOF

2023
CN2023/122615

ANTI-GPR183 ANTIBODIES AND USES THEREOF

2023
CN2023/079498

COMPOUNDS AND THEIR USES AS LPAR5 ANTAGONISTS

2023
CN2022/143352

ANTI-CCR6 ANTIBODIES AND PREPARATION METHOD AND USES THEREOF

2022
CN2022/125632

COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS

2022
CN2022/101000

ANTI-CCR8 ANTIBODIES AND USES THEREOF

2022
CN2022/089735

COMPOUNDS AND THEIR USES AS CD38 INHIBITORS

2022
CN2020/117267

ANTI-ROR1 ANTIBODIES AND PREPARATION METHOD AND USES THEREOF

2020
CN2020/117268

ROR1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR THERAPEUTIC APPLICATIONS

2020
CN2020/100026

METHODS ADN COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS

2020
CN2020/097572

COMPOUNDS AND THEIR USES AS MIF INHIBITORS

2020

1

上一页 1/1 下一页

About
Pipeline
- IPG11406 IPG1094
- IPG7236 IPG0521
- IPG8294 IPG6620
- IPG0916
Publications
- Paper
- Patent
News
- Press Release
- Media Reports
Careers
- Join Us

Cpyright © 2025 Nanjing Immunophage Biomedical Co.,Ltd

All Rights Reserved. 苏ICP备2022026466号-1 苏公网安备 32011202000830号